Clinical trial
Strategies for Individualized Management of Head and Neck Cancer
NCT07909603 is registered in ClinicalTrials.gov with Aarhus University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Strategies for Individualized Management of Head and Neck Cancer
- Lead sponsor
- Aarhus University Hospital
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- October 1, 2026
- Completion date
- July 31, 2038
- Enrollment
- 1,500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
head and neck cancer (h&n), thyroid cancer
Primary endpoints
Registered primary outcome measures; 3 primary.
-
Number of somatic variants in head- and neck cancer based on DNA sequencing data
WGS on tumor tissue
-
Number of RNA alterations in head- and neck cancer based on RNA sequencing data
Total RNA sequencing in tumor tissue
-
Prevalence of ctDNA in blood in head- and neck cancer patients before and after treatment
WGS
Lead sponsor's other trials
Aarhus University Hospital, most recent start first.
+292 more trials See the organization page
Similar trials
Same condition (Thyroid Neoplasms) and phase, most recent start first.
+224 more trials See the condition page